Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Suter

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Virology|December 16, 2011
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulenceMarc Schweneker, Susanne Lukassen, Michaela Späth, et al.
The Journal of Clinical Investigation|April 10, 2008
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protectionChristofer Samuelsson, Jürgen Hausmann, Henning Lauterbach, et al.
Vaccine|June 23, 2009
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strainMark Suter, Christine Meisinger-Henschel, Maria Tzatzaris, et al.
Journal of Virology|June 12, 2010
Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responsesKaren Baur, Kay Brinkmann, Marc Schweneker, et al.
The Journal of Experimental Medicine|March 5, 2003
Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infectionsSabine Vollstedt, Marco Franchini, Hans P Hefti, et al.
Frontiers in Immunology|July 1, 2022
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV InfectionKathrin Endt, Yvonne Wollmann, Jana Haug, et al.
Immunology|December 28, 2017
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient miceBarbara Bathke, Juliane Pätzold, Ronny Kassub, et al.
The Journal of General Virology|November 21, 2007
Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus AnkaraChristine Meisinger-Henschel, Michaela Schmidt, Susanne Lukassen, et al.
Journal of Virology|July 30, 2010
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in miceChristine Meisinger-Henschel, Michaela Späth, Susanne Lukassen, et al.
Particle and Fibre Toxicology|June 25, 2017
MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silicaHans Christian Winkler, Julian Kornprobst, Peter Wick, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Virology|December 16, 2011
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulenceMarc Schweneker, Susanne Lukassen, Michaela Späth, et al.
The Journal of Clinical Investigation|April 10, 2008
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protectionChristofer Samuelsson, Jürgen Hausmann, Henning Lauterbach, et al.
Vaccine|June 23, 2009
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strainMark Suter, Christine Meisinger-Henschel, Maria Tzatzaris, et al.
Journal of Virology|June 12, 2010
Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responsesKaren Baur, Kay Brinkmann, Marc Schweneker, et al.
The Journal of Experimental Medicine|March 5, 2003
Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infectionsSabine Vollstedt, Marco Franchini, Hans P Hefti, et al.
Frontiers in Immunology|July 1, 2022
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV InfectionKathrin Endt, Yvonne Wollmann, Jana Haug, et al.
Immunology|December 28, 2017
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient miceBarbara Bathke, Juliane Pätzold, Ronny Kassub, et al.
The Journal of General Virology|November 21, 2007
Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus AnkaraChristine Meisinger-Henschel, Michaela Schmidt, Susanne Lukassen, et al.
Journal of Virology|July 30, 2010
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in miceChristine Meisinger-Henschel, Michaela Späth, Susanne Lukassen, et al.
Particle and Fibre Toxicology|June 25, 2017
MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silicaHans Christian Winkler, Julian Kornprobst, Peter Wick, et al.
Pageof 4